Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02842723
Other study ID # IC 2008-01
Secondary ID
Status Completed
Phase Phase 2
First received
Last updated
Start date March 2010
Est. completion date February 2, 2021

Study information

Verified date January 2024
Source Institut Curie
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Prospective, open labelled, phase II, monocenter trial to combine partial surgery resection and protontherapy to management paediatric craniopharyngioma.


Description:

This study is phase II prospective, open labelled, phase ii, monocenter. The main objective is to evaluate the fractionated high precision radiotherapy with a dose of 59,5 Gy (1,7 Gy daily, 5 fractions per week).


Recruitment information / eligibility

Status Completed
Enrollment 33
Est. completion date February 2, 2021
Est. primary completion date November 13, 2018
Accepts healthy volunteers No
Gender All
Age group 3 Years to 16 Years
Eligibility Inclusion Criteria: - Histologically documented craniopharyngioma - Age range between 3 and 16 years - Landsky performance status > 60 - Incomplete surgical resection or simple biopsy - Solid and/or cystic aspect on imaging - Irradiation performed at the time of presentation or of local progression - Signed informed consent by parents or by legal representative (with copy to each participating center) Exclusion Criteria: - Previous history of radiotherapy (including stereotactic) administered to the head and neck region - Severe vasculopathy - Participation to a concurrent study - Contra-indication to general anesthesia in children below 5 years - Patient non-compliant to a minimum 30 mn immobilisation - Patient deprived of freedom or under guardianship - Patient not expected to be followed in a long run

Study Design


Related Conditions & MeSH terms


Intervention

Radiation:
Protontherapy
59,5 Gy (1,7 Gy daily, 5 fractions per week).

Locations

Country Name City State
France Groupe Hospitalier Necker Enfants Malades Paris
France Institut Curie Paris
France Gustave Roussy Villejuif

Sponsors (1)

Lead Sponsor Collaborator
Institut Curie

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary local control rate at 3 years of a minimally aggressive surgical resection, followed by fractionated high precision radiotherapy at 3 years
Secondary visual pathway tolerance according to NCI-CTC v3.0 scale through study completion, up to 9 years
See also
  Status Clinical Trial Phase
Active, not recruiting NCT00949156 - Tumor Classification and Its Application in Surgical Treatment of Craniopharyngioma Phase 1
Recruiting NCT05465174 - Nivolumab and Tovorafenib for Treatment of Craniopharyngioma in Children and Young Adults Phase 2
Recruiting NCT05525273 - Treatment of BRAF ( B-Rapidly Accelerated Fibrosarcoma) Mutated Papillary Craniopharyngioma Phase 2
Completed NCT02849743 - Intranasal Oxytocin in Hypothalamic Obesity Phase 2
Completed NCT01272622 - Prospective Study of Children and Adolescents With Craniopharyngioma N/A
Recruiting NCT04158284 - Multicenter Registry for Patients With Childhood.Onset Craniopharyngioma, Xanthogranuloma, Cysts of Rathke's Pouch, Meningioma, Pituitary Adenoma, Arachnoid Cysts
Completed NCT03194906 - Memantine for Prevention of Cognitive Late Effects in Pediatric Patients Receiving Cranial Radiation Therapy for Localized Brain Tumors Phase 2
Recruiting NCT06217848 - The Effect of GLP-1 Agonist in Patients With Hypothalamic Obesity: Prospective, Pilot Study Early Phase 1
Completed NCT01881854 - Sleep Wake and Melatonin Pattern in Craniopharyngioma N/A
Active, not recruiting NCT00517959 - SCRT Versus Conventional RT in Children and Young Adults With Low Grade and Benign Brain Tumors Phase 3
Not yet recruiting NCT06299891 - Efficacy and Safety of Phentermine/Topiramate in Youth With Hypothalamic Obesity Phase 2
Recruiting NCT02792582 - A Phase II Trial of Intensity-Modulated Proton Therapy for Incompletely Resected Craniopharyngioma and Observation for Craniopharyngioma After Radical Resection Phase 2
Completed NCT01484873 - Weight Loss Study for Patients With Obesity Due to Craniopharyngioma or Other Brain Tumor Phase 2
Withdrawn NCT03708913 - Neuromodulation for Hypothalamic Obesity N/A
Completed NCT02162732 - Molecular-Guided Therapy for Childhood Cancer N/A
Recruiting NCT00840047 - Methionine PET/CT Studies In Patients With Cancer Phase 2
Recruiting NCT04087902 - Long-Term Longitudinal QoL in Patients Undergoing EEA
Recruiting NCT04648462 - Proton Therapy Research Infrastructure- ProTRAIT- Neuro-oncology
Completed NCT04937335 - Craniopharyngioma With Tumoral Hemorrhage
Completed NCT03330080 - Examination of Sleep and Family Functioning in Pediatric Craniopharyngioma Patients